630 related articles for article (PubMed ID: 30648737)
21. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
22. The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.
Raffaelli B; Reuter U
Neurotherapeutics; 2018 Apr; 15(2):324-335. PubMed ID: 29616494
[TBL] [Abstract][Full Text] [Related]
23. CGRP antagonists: hope for a new era in acute migraine treatment.
Schelstraete C; Paemeleire K
Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
[TBL] [Abstract][Full Text] [Related]
24. Role of Monoclonal Antibodies against Calcitonin Gene-Related Peptide (CGRP) in Episodic Migraine Prevention: Where Do We Stand Today?
Nagaraj K; Vandenbussche N; Goadsby PJ
Neurol India; 2021; 69(Supplement):S59-S66. PubMed ID: 34003149
[TBL] [Abstract][Full Text] [Related]
25. [Novel migraine treatment with CGRP-related monoclonal antibodies].
Shibata M
Rinsho Shinkeigaku; 2020 Oct; 60(10):668-676. PubMed ID: 32893246
[TBL] [Abstract][Full Text] [Related]
26. Pain pharmacology in migraine: focus on CGRP and CGRP receptors.
Benemei S; Nicoletti P; Capone JA; Geppetti P
Neurol Sci; 2007 May; 28 Suppl 2():S89-93. PubMed ID: 17508187
[TBL] [Abstract][Full Text] [Related]
27. CGRP - a target for acute therapy in migraine: Clinical data.
Messina R; Goadsby PJ
Cephalalgia; 2019 Mar; 39(3):420-427. PubMed ID: 29616830
[TBL] [Abstract][Full Text] [Related]
28. Calcitonin gene-related peptide receptor antagonists for migraine.
Fischer MJ
Expert Opin Investig Drugs; 2010 Jul; 19(7):815-23. PubMed ID: 20482328
[TBL] [Abstract][Full Text] [Related]
29. CGRP receptor antagonism and migraine.
Edvinsson L; Ho TW
Neurotherapeutics; 2010 Apr; 7(2):164-75. PubMed ID: 20430315
[TBL] [Abstract][Full Text] [Related]
30. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
Edvinsson L; Warfvinge K
Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.
Chiang CC; Schwedt TJ
Prog Brain Res; 2020; 255():143-170. PubMed ID: 33008505
[TBL] [Abstract][Full Text] [Related]
32. CGRP receptors in the control of pain and inflammation.
Benemei S; Nicoletti P; Capone JG; Geppetti P
Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
[TBL] [Abstract][Full Text] [Related]
33. Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-Successful translation of basic science to clinical practice.
Edvinsson L
J Intern Med; 2022 Oct; 292(4):575-586. PubMed ID: 35532284
[TBL] [Abstract][Full Text] [Related]
34. Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine.
Caronna E; Starling AJ
Neurol Clin; 2021 Feb; 39(1):1-19. PubMed ID: 33223077
[TBL] [Abstract][Full Text] [Related]
35. Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman's life: Implications for the efficacy and safety of novel antimigraine medications.
de Vries Lentsch S; Rubio-Beltrán E; MaassenVanDenBrink A
Maturitas; 2021 Mar; 145():73-77. PubMed ID: 33541566
[TBL] [Abstract][Full Text] [Related]
36. Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants.
Do TP; Al-Saoudi A; Ashina M
Rev Neurol (Paris); 2021 Sep; 177(7):827-833. PubMed ID: 34294458
[TBL] [Abstract][Full Text] [Related]
37. CGRP and migraine: from bench to bedside.
Edvinsson L
Rev Neurol (Paris); 2021 Sep; 177(7):785-790. PubMed ID: 34275653
[TBL] [Abstract][Full Text] [Related]
38. Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.
Santos-Lasaosa S; Belvís R; Cuadrado ML; Díaz-Insa S; Gago-Veiga A; Guerrero-Peral AL; Huerta M; Irimia P; Láinez JM; Latorre G; Leira R; Pascual J; Porta-Etessam J; Sánchez Del Río M; Viguera J; Pozo-Rosich P
Neurologia (Engl Ed); 2022 Jun; 37(5):390-402. PubMed ID: 35672126
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.
Bigal ME; Walter S
CNS Drugs; 2014 May; 28(5):389-99. PubMed ID: 24638916
[TBL] [Abstract][Full Text] [Related]
40. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
Villalón CM; Olesen J
Pharmacol Ther; 2009 Dec; 124(3):309-23. PubMed ID: 19796656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]